Tilray | TRLY - Crediti Commerciali





Crediti Commerciali Cambiamento Data
Acasti Pharma USD 20K 0 2025-09
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Avita Medical AUD 9.11M 2.26M 2025-12
Canopy Growth CAD 36.29M 104.13M 2026-03
Cronos Group USD 59.76M 13.41M 2026-06
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
IQVIA Holdings USD 3.39B 12M 2026-06
Knight Therapeutics CAD 183M 7.46M 2025-12
Moderna USD 17M 54M 2026-06
Organigram Holdings CAD 53.39M 3.45M 2026-03
Organon & Co USD 1.49B 108M 2026-06
Revvity USD 709.18M 17.79M 2026-06
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.13B 49.9M 2026-06
Xeris Pharmaceuticals USD 56.29M 5.24M 2026-03
Zealand Pharma A/S 259M 81M 2026-03